Mycoplasma hyopneumoniae-induced disease

CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources

Volumn 1, Issue , 2006, Pages

  Thacker, Eileen ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Diagnosis; Epidemiology; Mycoplasma hyopneumoniae; Pigs

Indexed keywords

EID: 84891717778     PISSN: None     EISSN: 17498848     Source Type: Journal    
DOI: 10.1079/PAVSNNR20061050     Document Type: Review

References (70)

1. Goodwin RF. Apparent reinfection of enzootic-pneumonia-free pig herds: search for possible causes. Veterinary Record 1985;116(26):690-4.
2. Calsamiglia M, Pijoan C. Colonisation state and colostral immunity to Mycoplasma hyopneumoniae of different parity sows. Veterinary Record 2000;146(18):530-2.
3. Rautiainen E, Wallgren P. Aspects of the transmission of protection against Mycoplasma hyopneumoniae from sow to offspring. Journal of Veterinary Medicine B, Infectious Diseases and Veterinary Public Health 2001;48(1):55-65.
4. Sibila M, Calsamiglia M, Vidal D, Badiella L, Aldaz A, Jensen JC. Dynamics of Mycoplasma hyopneumoniae infection in 12 farms with different production systems. Canadian Journal of Veterinary Research 2004;68(1):12-8.
5. Vicca J, Maes D, Thermote L, Peeters J, Haesebrouck F, de Kruif A. Patterns of Mycoplasma hyopneumoniae infections in Belgian farrow-to-finish pig herds with diverging disease-course. Journal of Veterinary Medicine B, Infectious Diseases and Veterinary Public Health 2002;49(7):349-53.
6. Piffer IA, Ross RF. Effect of age on susceptibility of pigs to Mycoplasma hyopneumoniae pneumonia. American Journal of Veterinary Research 1984;45(3):478-81.
7. Thacker EL, Halbur PG, Ross RF, Thanawongnuwech R, Thacker BJ. Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia. Journal of Clinical Microbiology 1999;37(3):620-7.
8. DeBey MC, Ross RF. Ciliostasis and loss of cilia induced by Mycoplasma hyopneumoniae in porcine tracheal organ cultures. Infection and Immunity 1994;62(12):5312-8.
9. Asai T, Okada M, Ono M, Mori Y, Yokomizo Y, Sato S. Detection of interleukin-6 and prostaglandin E2 in bronchoalveolar lavage fluids of pigs experimentally infected with Mycoplasma hyponeumoniae. Veterinary Immunology and Immunopathology 1994;44(1):97-102.
10. Asai T, Okada M, Ono M, Irisawa T, Mori Y, Yokomizo Y, et al. Increased levels of tumor necrosis factor and interleukin 1 in bronchoalveolar lavage fluids from pigs infected with Mycoplasma hyopneumoniae. Veterinary Immunology and Immunopathology 1993;38(3-4):253-60.
11. Thacker EL, Thacker BJ, Kuhn M, Hawkins PA, Waters WR. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs. American Journal of Veterinary Research 2000;61(11):1384-9.
12. Ciprian A, Cruz TA, de la Garza M. Mycoplasma hyopneumoniae: interaction with other agents in pigs, and evaluation of immunogens. Archives of Medical Research 1994;25(2):235-9.
13. Shibata I, Okada M, Urono K, Samegai Y, Ono M, Sakano T, et al. Experimental dual infection of cesarean-derived, colostrum-deprived pigs with Mycoplasma hyopneumoniae and pseudorabies virus. The Journal of Veterinary Medical Science 1998;60(3):295-300.
14. Ellis R (editor). A model for PCV2 and Mycoplasma hyopneumoniae induced porcine respiratory disease complex. 84th Annual Meeting of Conference of Research Workers in Animal Diseases. 9-11. November 2003; Iowa State Press, Chicago, IL, USA.
15. Thacker EL, Thacker BJ, Janke BH. Interaction between Mycoplasma hyopneumoniae and swine influenza virus. Journal of Clinical Microbiology 2001;39(7):2525-30.
16. Friis NF. [Mycoplasms of the swine - a review]. Nordisk Veterinaer Medicin 1975;27(6):329-36.
17. Bereiter M, Young TF, Joo HS, Ross RF. Evaluation of the ELISA and comparison to the complement fixation test and radial immunodiffusion enzyme assay for detection of antibodies against Mycoplasma hyopneumoniae in swine serum. Veterinary Microbiology 1990;25(23):177-92.
18. Nicolet J, Paroz P, Bruggmann S. Tween 20 soluble proteins of Mycoplasma hyopneumoniae as antigen for an enzyme linked immunosorbent assay. Research in Veterinary Science 1980;29(3):305-9.
19. Erlandson K, Thacker B, Wegner M, Evans R, Thacker E. Evaluation of three serum antibody ELISA tests for Mycoplasma hyopneumoniae. The 17th Congress of the International Pig Veterinary Society. Ames, IA; 2002. p. 74.
20. Sorensen V, Ahrens P, Barfod K, Feenstra AA, Feld NC, Friis NF, et al. Mycoplasma hyopneumoniae infection in pigs: duration of the disease and evaluation of four diagnostic assays. Veterinary Microbiology 1997;54(1):23-34.
21. Strait E, Madsen ML, Minion FC, Thacker EL. Analysis of Mycoplasma hyopneumoniae field isolates. Conference of Research Workers in Animal Diseases; 9-11 November, 2003; Blackwell Press, Chicago, IL. p. 13.
22. Vicca J, Stakenborg T, Maes D, Butaye P, Peeters J, de Kruif A, Haesebrouck F. Evaluation of virulence of Mycoplasma hyopneumoniae field isolates. Veterinary Microbiology 2003;97(3-4):177-90.
23. Andreasen M, Mousing J, Krogsgaard Thomsen L. No simple association between time elapsed from seroconversion until slaughter and the extent of lung lesions in Danish swine. Preventive Veterinary Medicine 2001;52(2):147-61.
24. Djordjevic SP, Eamens GJ, Romalis LF, Nicholls PJ, Taylor V, Chin J. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant. Australian Veterinary Journal 1997;75(7):504-11.
25. Thacker EL, Thacker BJ, Boettcher TB, Jayappa H. Comparison of antibody production, lymphocyte stimulation, and protection induced by four commercial Mycoplasma hyopneumoniae bacterins. Swine Health and Production 1998;6(3):107-12.
26. Artiushin S, Stipkovits L, Minion FC. Development of polymerase chain reaction primers to detect Mycoplasma hyopneumoniae. Molecular and Cellular Probes 1993;7(5):381-5.
27. Calsamiglia M, Pijoan C, Trigo A. Application of a nested polymerase chain reaction assay to detect Mycoplasma hyopneumoniae from nasal swabs. Journal of Veterinary Diagnostic Investigation 1999;11(3):246-51.
28. Harasawa R, Koshimizu K, Takeda O, Uemori T, Asada K, Kato I. Detection of Mycoplasma hyopneumoniae DNA by the polymerase chain reaction. Molecular and Cellular Probes 1991;5(2):103-9.
29. Mattsson JG, Bergstrom K, Wallgren P, Johansson KE. Detection of Mycoplasma hyopneumoniae in nose swabs from pigs by in vitro amplification of the 16S rRNA gene. Journal of Clinical Microbiology 1995;33(4):893-7.
30. Stark KD, Nicolet J, Frey J. Detection of Mycoplasma hyopneumoniae by air sampling with a nested PCR assay. Applied and Environmental Microbiology 1998;64(2):543-8.
31. Stemke GW. Gene amplification (PCR) to detect and differentiate mycoplasmas in porcine mycoplasmal pneumonia. Letters in Applied Microbiology 1997; 25(5):327-30.
32. Verdin E, Saillard C, Labbe A, Bove JM, Kobisch M. A nested PCR assay for the detection of Mycoplasma hyopneumoniae in tracheobronchiolar washings from pigs. Veterinary Microbiology 2000;76(1):31-40.
33. Kurth KT, Hsu T, Snook ER, Thacker EL, Thacker BJ, Minion FC. Use of a Mycoplasma hyopneumoniae nested polymerase chain reaction test to determine the optimal sampling sites in swine. Journal of Veterinary Diagnostic Investigation 2002;14(6):463-9.
34. Calsamiglia M, Collins JE, Pijoan C. Correlation between the presence of enzootic pneumonia lesions and detection of Mycoplasma hyopneumoniae in bronchial swabs by PCR. Veterinary Microbiology 2000;76(3):299-303.
35. Dubosson CR, Conzelmann C, Miserez R, Boerlin P, Frey J, Zimmermann W, et al. Development of two real-time PCR assays for the detection of Mycoplasma hyopneumoniae in clinical samples. Veterinary Microbiology 2004;102(1-2):55-65.
36. Cooper AC, Fuller JR, Fuller MK, Whittlestone P, Wise DR. In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importance. Research in Veterinary Science 1993;54(3):329-34.
37. Thacker EL, Young TF, Erickson BZ, DeBey MC. Evaluation of tilmicosin's ability to prevent adherence of Mycoplasma hyopneumoniae to cilia using a differentiated swine epithelial culture system. Veterinary Therapeutics 2001;2(4):293-300.
38. Wu CC, Shryrock TR, Lin TL, Fleck M. Testing antimicrobial susceptibility against Mycoplasma hyopneumoniae in vitro. Swine Health and Production 1997;5(6):227-30.
39. Hannan PC, Bhogal BS, Fish JP. Tylosin tartrate and tiamutilin effects on experimental piglet pneumonia induced with pneumonic pig lung homogenate containing mycoplasmas, bacteria and viruses. Research in Veterinary Science 1982;33(1):76-88.
40. Ross RF, Cox DF. Evaluation of tiamulin for treatment of mycoplasmal pneumonia in swine. Journal of the American Veterinary Medical Association 1988;193(4):441-6.
41. Vicca J, Stakenborg T, Maes D, Butaye P, Peeters J, de Kruif A, et al. In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates. Antimicrobial Agents and Chemotheraphy 2004;48(11):4470-2.
42. Thacker EL, Thacker BJ, Wolff T. Efficacy of a chlortetracycline feed additive in reducing pneumonia and clinical signs induced by experimental Mycoplasma hyopneumoniae challenge. Journal of Swine Health and Production 2006;14(3):140-4.
43. Hsu FS, Yeh TP, Lee CT. Tiamulin feed medication for the maintenance of weight gains in the presence of mycoplasmal pneumonia in swine. Journal of Animal Science 1983;57(6):1474-8.
44. Mateusen B, Maes D, Hoflack G, Verdonck M, de Kruif A. A comparative study of the preventive use of tilmicosin phosphate (Pulmotil premix) and Mycoplasma hyopneumoniae vaccination in a pig herd with chronic respiratory disease. Journal of Veterinary Medicine B, Infectious Diseases and Veterinary Public Health 2001;48(10):733-41.
45. Mateusen B, Maes D, Van Goubergen M, Verdonck M, de Kruif A. Effectiveness of treatment with lincomycin hydrochloride and/or vaccination against Mycoplasma hyopneumoniae for controlling chronic respiratory disease in a herd of pigs. Veterinary Record 2002;151(5):135-40.
46. Bousquet E, Pommier P, Wessel-Robert S, Morvan H, Benoit-Valiergue H, Laval A. Efficacy of doxycycline in feed for the control of pneumonia caused by Pasteurella multocida and Mycoplasma hyopneumoniae in fattening pigs. Veterinary Record 1998;143(10):269-72.
47. Burch DG, Jones GT, Heard TW, Tuck RE. The synergistic activity of tiamulin and chlortetracycline: in-feed treatment of bacterially complicated enzootic pneumonia in fattening pigs. Veterinary Record 1986;119(5):108-12.
48. Stipkovits L, Miller D, Glavits R, Fodor L, Burch D. Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics. Canadian Journal of Veterinary Research 2001;65(4):213-22.
49. Stakenborg T, Vicca J, Butaye P, Maes D, Minion FC, Peeters J, et al. Characterization of in vivo acquired resistance of Mycoplasma hyopneumoniae to macrolides and lincosamides. Microbial Drug Resistance 2005;11(3):290-4.
50. Maes D, Verdonck M, Deluyker H, de Kruif A. Enzootic pneumonia in pigs. The Veterinary Quarterly 1996; 18(3):104-9.
51. Zimmerman W, Odermatt W, Tschudi P. Enzootic pneumonia (EP): the partial depopulation of sow farms reinfected with EP as an alternative to the complete depopulation. Schweizer Archir fur Tierheilkunde 1989;179-91.
52. Baekbo P, Kooij D, Mortensen S, Barfod K, Mousing J. Economic evaluation of national eradication and control strategies for Mycoplasma hyopneumoniae in Denmark. Acta Veternaria Scandinavica Supplement 1996;90:63-5.
53. Heinonen M, Autio T, Saloniemi H, Tuovinen V. Eradication of Mycoplasma hyopneumoniae from infected swine herds joining the LSO 2000 health class. Acta Veterinary Scandinavia 1999;40(3):241-52.
54. Rautiainen E, Oravainen J, Virolainen JV, Tuovinen V. Regional eradication of Mycoplasma hyopneumoniae from pig herds and documentation of freedom of the disease. Acta Veterinary Scandinavia 2001;42(3):355-64.
55. Stark KD, Keller H, Eggenberger E. Risk factors for the reinfection of specific pathogen-free pig breeding herds with enzootic pneumonia. Veterinary Record 1992;131:532-535.
56. Hege R, Zimmermann W, Scheidegger R, Stark KD. Incidence of reinfections with Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae in pig farms located in respiratory-disease-free regions of Switzerland - identification and quantification of risk factors. Acta Veterinary Scandinavia 2002;43(3):145-56.
57. Alexander TJ, Thornton K, Boon G, Lysons RJ, Gush AF. Medicated early weaning to obtain pigs free from pathogens endemic in the herd of origin. Veterinary Record 1980;106(6):114-9.
58. Dohoo IR, Montgomery ME. A field trial to evaluate a Mycoplasma hyopneumoniae vaccine: effects on lung lesions and growth rates in swine. The Canadian Veterinary Journal 1996;37(5):299-302.
59. Jensen CS, Ersboll AK, Nielsen JP. A meta-analysis comparing the effect of vaccines against Mycoplasma hyopneumoniae on daily weight gain in pigs. Preventive Veterinary Medicine 2002;54(3):265-78.
60. Maes D, Deluyker H, Verdonck M, Castryck F, Miry C, Lein A, et al. Effect of vaccination against Mycoplasma hypopneumoniae in pig herds with a continuous production system. Zentralblatt fur Veterinarmedizin B 1998;45(8): 495-505.
61. Kobisch M, Quillien L, Tillon JP, Wroblewski H. The Mycoplasma hyopneumoniae plasma membrane as a vaccine against porcine enzootic pneumonia. Annales de l'Institut Pasteur, Immunology 1987;138(5):693-705.
62. Kristensen B, Paroz P, Nicolet J, Wanner M, de Weck AL. Cell-mediated and humoral immune response in swine after vaccination and natural infection with Mycoplasma hyopneumoniae. American Journal of Veterinary Research 1981;42(5):784-8.
63. Messier S, Ross RF, Paul PS. Humoral and cellular immune responses of pigs inoculated with Mycoplasma hyopneumoniae. American Journal of Veterinary Research 1990;51(1):52-8.
64. Ross RF, Zimmermann-Erickson BJ, Young TF. Characteristics of protective activity of Mycoplasma hyopneumoniae vaccine. American Journal of Veterinary Research 1984;45(10):1899-905.
65. Sheldrake RF, Romalis LF, Saunders MM. Serum and mucosal antibody responses against Mycoplasma hyopneumoniae following intraperitoneal vaccination and challenge of pigs with M. hyopneumoniae. Research in Veterinary Science 1993;55(3):371-6.
66. Thacker BJ and Thacker EL. Influence of Maternally-derived Antibodies on the Efficacy of a Mycoplasma hyopneumoniae Bacterin. American Association of Swine Veterinarians, Nashville, TN; 2001. p. 513-5.
67. Jayappa H, Davis R, Rapp-Gabrielson V, Wasmoen T, Thacker E, Thacker B. Evaluation of the Efficacy of Mycoplasma hyopneumoniae Bacterin Following Immunization of Young Pigs in the Presence of Varying Levels of Maternal Antibodies. American Association of Swine Veterinarians, Nashville, TN; 2001. p. 237-41.
68. Thacker EL, Thacker BJ, Young TF, Halbur PG. Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae. Vaccine 2000;18(13):1244-52.
69. Moreau IA, Miller GY, Bahnson PB. Effects of Mycoplasma hyopneumoniae vaccine on pigs naturally infected with M. hyopneumoniae and porcine reproductive and respiratory syndrome virus. Vaccine 2004;22(17-18):2328-33.
70. Maes D, Deluyker H, Verdonck M, Castryck F, Miry C, Vrijens B, et al. Effect of vaccination against Mycoplasma hyopneumoniae in pig herds with an all-in/all-out production system. Vaccine 1999;17(9-10):1024-34.